A group of Danish investors is attempting to thwart the takeover of Bavarian Nordic by two private equity funds. These funds are seeking to acquire the Danish pharmaceutical company at a price deemed too low by many private investors.

Spearheaded by the Danish Shareholders’ Association, the investor group is actively working to prevent the acquisition. They believe the current offer undervalues Bavarian Nordic’s potential.

The situation surrounding Bavarian Nordic has been intensifying. The counter-move by Danish investors represents a significant development in the ongoing struggle for control of the company.